Form 4: LifeStance Health Director Sells Shares in Multiple Transactions

LifeStance Health Group director Robert Bessler sold 75,000 shares of common stock on November 27, 2024, at an average price of $7.54 per share.

Summary

• Robert Bessler, a director at LifeStance Health Group, sold 75,000 shares of common stock on November 27, 2024.
• The sales were executed at a weighted average price of $7.54 per share.
• The transactions were conducted through multiple sales with prices ranging from $7.45 to $7.59.
• Following the transactions, Bessler still beneficially owns 1,424,447 shares indirectly through Vitthal LLC, 1,541,247 shares indirectly through Shama LLC, 21,905 shares directly, and 36,363 shares indirectly through Alpine Glow Capital.
• Bessler disclaims beneficial ownership of shares held through Vitthal LLC, Shama LLC, and Alpine Glow Capital except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a neutral disclosure of a stock sale by a director, with no inherent positive or negative sentiment.

Risks

• The sale of a significant number of shares by a director could be perceived negatively by the market.

Industry Context

This is a routine disclosure of insider trading activity, which is common in publicly traded companies. The sale by a director is a normal part of the market.

Comparison to Industry Standards

• Insider trading activity is a common occurrence in publicly listed companies, and this transaction is similar to other Form 4 filings.
• The volume of shares sold is not unusual for a director's transaction, and the price range is within normal market fluctuations.

Stakeholder Impact

• The sale of shares by a director could have a minor impact on shareholder sentiment.

Key Dates

Keywords

LifeStance Health Group, LFST, Robert Bessler, insider trading, share sale, Form 4, director, stock transaction